Status:
COMPLETED
Follow-up Assessment of a Trial of Open-label Placebos for Women With Premenstrual Syndrome
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Premenstrual Syndrome
Eligibility:
FEMALE
Brief Summary
With the proposed study, the investigators aim to evaluate the long-term efficacy of the open-label placebo (OLP) intervention in premenstrual syndrome (PMS) and to contribute to a broader understandi...
Eligibility Criteria
Inclusion
- Participants are willing to participate in the follow-up study
- Participants have the ability to use an electronic device with internet access to complete the online follow-up survey
- Participants give Informed consent
- Participants have a regular menstruation (i.e., no menopause; pregnancy; cycle inhibiting medication etc.)
Exclusion
- Pregnancy or breastfeeding (currently or within the last three months)
- A severe psychological or somatic disease, affecting premenstrual complaints (e.g., cancer of the uterus or fallopian tubes)
- Commencement of the menopause, sterilization, or (part) resection of the uterus or fallopian tubes
- Changes in body mass index (i.e., under 18 or above 30)
Key Trial Info
Start Date :
January 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 3 2024
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06206460
Start Date
January 4 2024
End Date
July 3 2024
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Basel, Faculty of Psychology, Division of Clinical Psychology and Psychotherapy
Basel, Switzerland, 4055